The most common neurological illness is Alzheimers, followed by Parkinsons and epilepsy (Nassan and Videnovic, 2022)
Joenja (FDA approved March 2023) Pharming received approval for Joenja (leniolisib), the first treatment for patients with activated PI3K Delta syndrome, an ultra-rare autoimmune disorder characterized by recurrent respiratory infections and immune dysregulation with only 200 identified patients in the U.S
Skin Barrier Repair Models In barrier-disruption models, GHK-Cu has been reported to support recovery of stratum-corneum lipid composition and tight-junction protein expression [6]
Research demonstrates that AHK-Cu treatment elevates the Bcl-2 to Bax ratio, effectively telling dermal papilla cells to survive longer
This page is educational measurement math, not triage advice
Interdisciplinary collaboration will also support the seamless integration of AI-driven systems within existing healthcare infrastructures, ensuring that these technologies are both effective and practical [252]